Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Complete Genome Sequence of an Ictalurid Herpesvirus 1 Strain Isolated from Blue Catfish (Ictalurus furcatus).

Subramaniam K, Venugopalan A, Davison AJ, Griffin MJ, Ford L, Waltzek TB, Hanson L.

Microbiol Resour Announc. 2019 Apr 11;8(15). pii: e00082-19. doi: 10.1128/MRA.00082-19.

2.

APOBEC Mutagenesis and Copy-Number Alterations Are Drivers of Proteogenomic Tumor Evolution and Heterogeneity in Metastatic Thoracic Tumors.

Roper N, Gao S, Maity TK, Banday AR, Zhang X, Venugopalan A, Cultraro CM, Patidar R, Sindiri S, Brown AL, Goncearenco A, Panchenko AR, Biswas R, Thomas A, Rajan A, Carter CA, Kleiner DE, Hewitt SM, Khan J, Prokunina-Olsson L, Guha U.

Cell Rep. 2019 Mar 5;26(10):2651-2666.e6. doi: 10.1016/j.celrep.2019.02.028.

3.

Quantitative Mass Spectrometry to Interrogate Proteomic Heterogeneity in Metastatic Lung Adenocarcinoma and Validate a Novel Somatic Mutation CDK12-G879V.

Zhang X, Nguyen KD, Rudnick PA, Roper N, Kawaler E, Maity TK, Awasthi S, Gao S, Biswas R, Venugopalan A, Cultraro CM, Fenyƶ D, Guha U.

Mol Cell Proteomics. 2019 Apr;18(4):622-641. doi: 10.1074/mcp.RA118.001266. Epub 2019 Jan 7.

PMID:
30617155
4.

Long term effectiveness of RA-1 as a monotherapy and in combination with disease modifying anti-rheumatic drugs in the treatment of rheumatoid arthritis.

Chopra A, Saluja M, Kianifard T, Chitre D, Venugopalan A.

J Ayurveda Integr Med. 2018 Jul - Sep;9(3):201-208. doi: 10.1016/j.jaim.2017.07.009. Epub 2018 Mar 9.

5.

Quantitative Tyrosine Phosphoproteomics of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor-treated Lung Adenocarcinoma Cells Reveals Potential Novel Biomarkers of Therapeutic Response.

Zhang X, Maity T, Kashyap MK, Bansal M, Venugopalan A, Singh S, Awasthi S, Marimuthu A, Charles Jacob HK, Belkina N, Pitts S, Cultraro CM, Gao S, Kirkali G, Biswas R, Chaerkady R, Califano A, Pandey A, Guha U.

Mol Cell Proteomics. 2017 May;16(5):891-910. doi: 10.1074/mcp.M117.067439. Epub 2017 Mar 22.

6.

Genomic profiling of multiple sequentially acquired tumor metastatic sites from an "exceptional responder" lung adenocarcinoma patient reveals extensive genomic heterogeneity and novel somatic variants driving treatment response.

Biswas R, Gao S, Cultraro CM, Maity TK, Venugopalan A, Abdullaev Z, Shaytan AK, Carter CA, Thomas A, Rajan A, Song Y, Pitts S, Chen K, Bass S, Boland J, Hanada KI, Chen J, Meltzer PS, Panchenko AR, Yang JC, Pack S, Giaccone G, Schrump DS, Khan J, Guha U.

Cold Spring Harb Mol Case Stud. 2016 Nov;2(6):a001263.

7.

EGFR-targeted therapy results in dramatic early lung tumor regression accompanied by imaging response and immune infiltration in EGFR mutant transgenic mouse models.

Venugopalan A, Lee MJ, Niu G, Medina-Echeverz J, Tomita Y, Lizak MJ, Cultraro CM, Simpson RM, Chen X, Trepel JB, Guha U.

Oncotarget. 2016 Aug 23;7(34):54137-54156. doi: 10.18632/oncotarget.11021.

8.

Reprint of: Effect of fermentation parameters, elicitors and precursors on camptothecin production from the endophyte Fusarium solani.

Venugopalan A, Potunuru UR, Dixit M, Srivastava S.

Bioresour Technol. 2016 Aug;213:311-318. doi: 10.1016/j.biortech.2016.05.023. Epub 2016 May 14.

PMID:
27189536
9.

Prevalence of hypercholesterolaemia among adults aged over 30 years in a rural area of north Kerala, India: a cross-sectional study.

Aslesh OP, Jayasree AK, Karunakaran U, Venugopalan AK, Divakaran B, Mayamol TR, Sunil CB, Minimol KJ, Shalini K, Mallar GB, Sani TPM.

WHO South East Asia J Public Health. 2016 Apr;5(1):70-75. doi: 10.4103/2224-3151.206557.

10.

Effect of fermentation parameters, elicitors and precursors on camptothecin production from the endophyte Fusarium solani.

Venugopalan A, Potunuru UR, Dixit M, Srivastava S.

Bioresour Technol. 2016 Apr;206:104-111. doi: 10.1016/j.biortech.2016.01.079. Epub 2016 Jan 29.

PMID:
26851893
11.

Endophytes as in vitro production platforms of high value plant secondary metabolites.

Venugopalan A, Srivastava S.

Biotechnol Adv. 2015 Nov 1;33(6 Pt 1):873-87. doi: 10.1016/j.biotechadv.2015.07.004. Epub 2015 Jul 28. Review.

PMID:
26225453
12.

Loss of MIG6 Accelerates Initiation and Progression of Mutant Epidermal Growth Factor Receptor-Driven Lung Adenocarcinoma.

Maity TK, Venugopalan A, Linnoila I, Cultraro CM, Giannakou A, Nemati R, Zhang X, Webster JD, Ritt D, Ghosal S, Hoschuetzky H, Simpson RM, Biswas R, Politi K, Morrison DK, Varmus HE, Guha U.

Cancer Discov. 2015 May;5(5):534-49. doi: 10.1158/2159-8290.CD-14-0750. Epub 2015 Mar 3.

13.

Enhanced camptothecin production by ethanol addition in the suspension culture of the endophyte, Fusarium solani.

Venugopalan A, Srivastava S.

Bioresour Technol. 2015;188:251-7. doi: 10.1016/j.biortech.2014.12.106. Epub 2015 Jan 8.

PMID:
25603728
14.

Identifying novel targets of oncogenic EGF receptor signaling in lung cancer through global phosphoproteomics.

Zhang X, Belkina N, Jacob HK, Maity T, Biswas R, Venugopalan A, Shaw PG, Kim MS, Chaerkady R, Pandey A, Guha U.

Proteomics. 2015 Jan;15(2-3):340-55. doi: 10.1002/pmic.201400315.

15.

Cytokines in acute chikungunya.

Venugopalan A, Ghorpade RP, Chopra A.

PLoS One. 2014 Oct 24;9(10):e111305. doi: 10.1371/journal.pone.0111305. eCollection 2014.

16.
17.

Ayurvedic medicine offers a good alternative to glucosamine and celecoxib in the treatment of symptomatic knee osteoarthritis: a randomized, double-blind, controlled equivalence drug trial.

Chopra A, Saluja M, Tillu G, Sarmukkaddam S, Venugopalan A, Narsimulu G, Handa R, Sumantran V, Raut A, Bichile L, Joshi K, Patwardhan B.

Rheumatology (Oxford). 2013 Aug;52(8):1408-17. doi: 10.1093/rheumatology/kes414. Epub 2013 Jan 30.

PMID:
23365148
18.

Evaluating higher doses of Shunthi - Guduchi formulations for safety in treatment of osteoarthritis knees: A Government of India NMITLI arthritis project.

Chopra A, Saluja M, Tillu G, Venugopalan A, Narsimulu G, Sarmukaddam S, Patwardhan B.

J Ayurveda Integr Med. 2012 Jan;3(1):38-44. doi: 10.4103/0975-9476.93948.

19.

Salivary immunoglobulin A in rheumatoid arthritis (RA) with focus on dental caries: a cross-sectional study.

Chopra M, Jadhav S, Venugopalan A, Hegde V, Chopra A.

Clin Rheumatol. 2012 Feb;31(2):247-50. doi: 10.1007/s10067-011-1796-0. Epub 2011 Jul 20.

PMID:
21773716
20.

Comparable efficacy of standardized Ayurveda formulation and hydroxychloroquine sulfate (HCQS) in the treatment of rheumatoid arthritis (RA): a randomized investigator-blind controlled study.

Chopra A, Saluja M, Tillu G, Venugopalan A, Narsimulu G, Handa R, Bichile L, Raut A, Sarmukaddam S, Patwardhan B.

Clin Rheumatol. 2012 Feb;31(2):259-69. doi: 10.1007/s10067-011-1809-z. Epub 2011 Jul 20.

PMID:
21773714
21.

A Randomized Controlled Exploratory Evaluation of Standardized Ayurvedic Formulations in Symptomatic Osteoarthritis Knees: A Government of India NMITLI Project.

Chopra A, Saluja M, Tillu G, Venugopalan A, Sarmukaddam S, Raut AK, Bichile L, Narsimulu G, Handa R, Patwardhan B.

Evid Based Complement Alternat Med. 2011;2011:724291. doi: 10.1155/2011/724291. Epub 2010 Oct 11.

22.

Profile of Indian patients with juvenile onset chronic inflammatory joint disease using the ILAR classification criteria for JIA: a community-based cohort study.

Kunjir V, Venugopalan A, Chopra A.

J Rheumatol. 2010 Aug 1;37(8):1756-62. doi: 10.3899/jrheum.090937. Epub 2010 Jun 1.

PMID:
20516021
23.

Analysis of Transcripts Expressed in One-Day-Old Larvae and Fifth Instar Silk Glands of Tasar Silkworm, Antheraea mylitta.

Maity S, Goel SI, Roy S, Ghorai S, Bhattacharyya S, Venugopalan A, Ghosh AK.

Comp Funct Genomics. 2010:246738. doi: 10.1155/2010/246738. Epub 2010 May 4.

24.

Unexpected newcastle disease virus in day old commercial chicks and breeder hen.

Roy P, Venugopalan AT.

Comp Immunol Microbiol Infect Dis. 2005 Jul;28(4):277-85. Epub 2005 Sep 23.

PMID:
16183120
25.

Antigenetically unusual Newcastle disease virus from racing pigeons in India.

Roy P, Venugopalan AT, Koteeswaran A.

Trop Anim Health Prod. 2000 Jun;32(3):183-8.

PMID:
10907290
26.

Characterization of Newcastle disease viruses isolated from chickens and ducks in Tamilnadu, India.

Roy P, Venugopalan AT, Manvell R.

Vet Res Commun. 2000 Mar;24(2):135-42.

PMID:
10720099
27.

Passive haemagglutination test in the serology of Newcastle disease virus.

Roy P, Venugopalan AT.

Trop Anim Health Prod. 2000 Feb;32(1):19-22. No abstract available.

PMID:
10717940
28.

Efficacy of live adjuvanted mesogenic Newcastle disease vaccine in chickens.

Roy P, Venugopalan AT, Koteeswaran A.

Vaccine. 1999 Jun 4;17(20-21):2674-6.

PMID:
10418918
29.

Dot-enzyme linked immunosorbent assay for demonstration of Newcastle disease virus infection.

Roy P, Venugopalan AT.

Comp Immunol Microbiol Infect Dis. 1999 Jan;22(1):27-31.

PMID:
10099026
30.

Velogenic Newcastle disease virus in captive wild birds.

Roy P, Venugopalan AT, Selvarangam R, Ramaswamy V.

Trop Anim Health Prod. 1998 Oct;30(5):299-303.

PMID:
9881435
31.

Isolation of Newcastle disease virus from an Indian house crow.

Roy P, Venugopalan AT, Manvell R.

Trop Anim Health Prod. 1998 Jun;30(3):177-8. No abstract available.

PMID:
9719846
32.

Pathogenicity and immunosuppressive properties of infectious bursal disease virus field isolates and commercial vaccines in India.

Thangavelu A, Raj GD, Elankumaran S, Manohar BM, Koteeswaran A, Venugopalan AT.

Trop Anim Health Prod. 1998 Jun;30(3):167-76.

PMID:
9719845
33.

Virulence of Newcastle disease vaccine virus(es) in the field.

Roy P, Venugopalan AT.

Trop Anim Health Prod. 1998 Feb;30(1):41-4. No abstract available.

PMID:
9719828
34.

Potentiation of immune response of live lentogenic Newcastle disease vaccine using adjuvant.

Roy P, Venugopalan AT.

Trop Anim Health Prod. 1998 Feb;30(1):37-9. No abstract available.

PMID:
9719827
35.

Comparison of Newcastle disease vaccines by serology using serum, tears and feather pulp samples.

Roy P, Koteeswaran A, Sridevi P, Venugopalan AT.

Trop Anim Health Prod. 1998 Feb;30(1):31-5.

PMID:
9719826
36.

Immunorheophoresis for the diagnosis of infectious bursal disease.

Raj GD, Jayakumar V, Thangavelu A, Koteeswaran A, Venugopalan AT.

Avian Dis. 1998 Apr-Jun;42(2):388-92.

PMID:
9645332
37.

Use of egg yolk in seromonitoring against Newcastle disease.

Roy P, Anandan S, Ravikumar G, Koteeswaran A, Venugopalan AT.

Trop Anim Health Prod. 1997 Nov;29(4):245-6. No abstract available.

PMID:
9493300
38.

Agar-gel-immunodiffusion and counterimmunoelectrophoresis for diagnosis of Newcastle disease.

Roy P, Venugopalan AT.

Trop Anim Health Prod. 1997 Nov;29(4):231-4.

PMID:
9493296
39.

Latex immunoassay for rapid detection of Newcastle disease virus.

Thirumurugan G, Jayakumar R, Kumanan K, Venugopalan AT, Nachimuthu K.

Trop Anim Health Prod. 1997 Nov;29(4):227-30.

PMID:
9493295
40.

Isolation of pestes des petits ruminants virus from an outbreak in Indian buffalo (Bubalus bubalis).

Govindarajan R, Koteeswaran A, Venugopalan AT, Shyam G, Shaouna S, Shaila MS, Ramachandran S.

Vet Rec. 1997 Nov 29;141(22):573-4. No abstract available.

PMID:
9423239
41.

Methanol-precipitated, detergent-treated Newcastle disease virus as an agar-gel precipitation test antigen.

Roy P, Koteeswaran A, Venugopalan AT.

Trop Anim Health Prod. 1997 Feb;29(1):25-8.

PMID:
9090012
42.

Postvaccinal immune response to regimens of Newcastle disease vaccination by filter paper sampling technique.

Roy P, Nachimuthu K, Koteeswaran A, Albert A, Venugopalan AT.

Trop Anim Health Prod. 1997 Feb;29(1):20-4.

PMID:
9090011
43.

Occurrence of rinderpest in European pigs in India.

Govindarajan R, Muralimanohar B, Koteeswaran A, Venugopalan AT, Varalakshmi P, Shaila MS, Ramachandran S.

Vet Rec. 1996 Nov 9;139(19):473. No abstract available.

PMID:
8938969
44.

Estimation of antibodies to Newcastle disease virus in tears.

Elankumaran S, Raj GD, Thangavelu A, Koteeswaran A, Albert A, Venugopalan AT.

Trop Anim Health Prod. 1996 Nov;28(4):293-7.

PMID:
8983134
45.

Suitable samples from remote areas for Newcastle disease diagnosis.

Roy P, Dhinakar RG, Koteeswaran A, Nachimuthu K, Venugopalan AT.

Trop Anim Health Prod. 1995 Aug;27(3):171-2. No abstract available.

PMID:
7502349
46.

Precipitation reactions with Newcastle disease virus.

Raj G, Thangavelu A, Govindarajan R, Nachimuthu K, Venugopalan AT.

Trop Anim Health Prod. 1995 May;27(2):71-5.

PMID:
7652941
47.

Filter paper technique for seromonitoring against infectious bursal disease.

Roy P, Nachimuthu K, Venugopalan AT, Dorairajan N, Purushothaman V, Koteeswaran A.

Trop Anim Health Prod. 1994 Nov;26(4):251-2. No abstract available.

PMID:
7900225
48.

Preferred basis in a measurement process.

Venugopalan A.

Phys Rev A. 1994 Sep;50(3):2742-2745. No abstract available.

PMID:
9911195
49.

Quantitative counter-immunoelectrophoresis for estimation of antibodies to infectious bursal disease virus.

Raj GD, Thangavelu A, Elankumaran S, Koteeswaran A, Venugopalan AT.

Vet Res Commun. 1994;18(4):289-93.

PMID:
7831758
50.

A modified filter paper technique for serosurveillance of Newcastle disease.

Roy P, Nachimuthu K, Venugopalan AT.

Vet Res Commun. 1992;16(5):403-6. No abstract available.

PMID:
1494864

Supplemental Content

Loading ...
Support Center